Clue vs. Balance for Perimenopause

These two are less alike than the category suggests. Clue is a period and cycle tracker headquartered in Berlin that, per its own policy, handles sensitive health data under strict EU data-protection rules; its Perimenopause mode adds symptom tracking and, per its makers, a cycle view that accounts for changing cycle lengths. Balance, from Newson Health and founded by Dr. Louise Newson, is a menopause app built around symptom tracking, a large library of evidence-based articles, and a Health Report for appointments; per its makers it has been recognized by the NHS and certified by ORCHA. Clue is a tracker that added midlife; Balance is a menopause product that includes tracking. Choose Clue for privacy and calm, cycle-aware logging. Choose Balance for education, clinical framing, and a report you can hand over.

If you are comparing these two, you are probably deciding between staying with a tracker you trust and moving to something built for the stage you are in. Both are defensible. Neither is a compromise.

We make a perimenopause app ourselves — Rythma — and note where that is relevant at the end. Everything below about Clue and Balance comes from each company's own published materials.

The stage they are both being judged against

Perimenopause usually begins in the mid- to late 40s and lasts about four years on average, sometimes as long as eight, according to the U.S. Office on Women's Health. Periods may run longer or shorter, heavier or lighter, skip months entirely, and you may not ovulate every cycle. The Cleveland Clinic describes hormone levels going up and down "like a rollercoaster" rather than declining smoothly.

The symptom load extends well past bleeding. In an international survey of more than 17,000 women across 158 countries analyzed by The Menopause Society, fatigue was the most reported symptom at 83%, ahead of irritability (80%), depressive mood (77%), and sleep problems (76%) — all outranking hot flashes at 71%.

So the two questions that separate these apps are: how gracefully does it handle an unpredictable cycle, and how much does it help you with everything else?

Clue — privacy, restraint, and a cycle view built for change

Clue is a long-running, science-forward period and cycle tracker. Its strongest differentiator is data handling: headquartered in Berlin and, per its own policy, subject to strict EU data-protection rules. In a category where reproductive health data is genuinely sensitive, that is a substantive reason to choose it rather than a marketing claim.

Clue Perimenopause adds symptom tracking for this stage and, per its makers, a cycle view designed to account for changing cycle lengths rather than simply reporting a period as late. That is a smaller-sounding change with a large practical effect: under the STRAW+10 staging system, the early menopause transition is defined by consecutive cycle lengths persistently differing by seven or more days, so an app that treats variation as the normal case is describing you accurately rather than flagging you as overdue.

Clue's general character is worth naming too. It is notably restrained and low-hype in a field full of confident claims, which some women find a relief and others find sparse.

Best for: privacy-conscious women who want a calm, science-forward tracker that flexes for irregularity.

Trade-offs: cycle-first by origin, so perimenopause is one mode among several; no article library on Balance's scale; no report designed for appointments. See the Clue perimenopause overview.

Balance — education, clinical framing, and a Health Report

Balance approaches from the opposite direction. It is a menopause product first, founded by Dr. Louise Newson through Newson Health, with symptom tracking as one component rather than the foundation.

Its defining asset is the library of evidence-based articles, paired with a Health Report you can take to appointments. According to its makers, Balance has been recognized by the NHS and certified by the digital-health assessor ORCHA.

What that combination buys you is standing. If your problem is not only "what is happening to me" but "I need to be taken seriously about it," a report from a clinician-founded, NHS-recognized product and the reading to explain what you are asking for is a genuinely different position to argue from.

Best for: women who want authoritative menopause education plus a report for appointments.

Trade-offs: broad menopause focus rather than perimenopause-specific prediction; some features sit behind a paid tier; less emphasis on cycle mechanics than Clue. See the Balance app page.

Head-to-head

Privacy. Clue, clearly. Read both current policies rather than relying on reputation, but the EU data-protection position is a real distinction.

Education. Balance, clearly. Clue publishes good material, but Balance's library and clinical authorship are its centre.

The appointment. Balance generates a Health Report; Clue leaves you to summarize your own log. Either way, logging is what lets you catch what the American College of Obstetricians and Gynecologists says warrants attention — very heavy bleeding (soaking a pad or tampon hourly for two or more hours), bleeding between periods or after sex, or cycles staying consistently closer than about 21 days.

Cycle handling. Clue's cycle view is more thoughtfully built for changing lengths; Balance treats the cycle as one input among many midlife symptoms. Which is better depends on how central bleeding still is to your experience — early in the transition it usually is, later it usually is not.

Tone. Clue is deliberately understated. Balance is more actively guiding. Some women want a calm instrument; others want an advocate.

What neither does. Neither forecasts which of your days are likely to be difficult. Clue records; Balance records and explains. Anticipation is a third capability — the one our own app, Rythma, is built around — and worth knowing about if your actual goal is to move a meeting off a bad day rather than to understand why the day was bad.

How to choose

• Privacy is your leading concern. Clue.
• You want to understand this thoroughly and argue your case. Balance.
• You want a report to hand a clinician. Balance generates one.
• Your cycle is still central and you want it tracked accurately. Clue.
• You want your hard days forecast. Neither — look at prediction-first apps.

Both are free to download with paid tiers, and using them together is not unreasonable: Clue as the logging instrument, Balance as the reference. Whatever you choose, log consistently, because everything either app offers depends on having enough data behind it.

About Rythma

Rythma is a perimenopause tracking app for iPhone that learns each user's personal symptom patterns and predicts difficult days before they arrive. Built specifically for the unpredictability of perimenopause — rather than the fixed 28-day cycle most period apps assume — it helps women anticipate symptoms, plan their lives around hard days, and bring a clear symptom report to their doctor.

Download Rythma on the App Store →

Related guides

• Considering a move? See Clue alternatives and Balance alternatives for perimenopause.
• Head-to-head with ours: Rythma vs. Clue and Rythma vs. Balance.
• Is Clue right for this stage? Read is Clue good for perimenopause?
• For the full field, see the best menopause apps in 2026.

---

Rythma is a tracking and educational tool, not a medical device, and this article is for general information only — it is not medical advice. Perimenopause varies widely from person to person. Always consult a qualified healthcare professional about your symptoms, diagnosis, or treatment.